Medicare Enrolled
Dr. Michael Chesner, MD
Cardiovascular Disease · Summerfield, FL
Practice pattern: Cardiac Imaging
— Practice with significant diagnostic imaging and stress testing
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Chesner from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chesner?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Chesner
Dr. Michael Chesner is a cardiovascular disease specialist in Summerfield, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Chesner performed 2,954 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Chesner received a total of $4,594 from 44 pharmaceutical and/or device companies across 184 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Chesner is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 44% volume in FL
$4,594 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 131789 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗2,954
Medicare services
Top 44% in FL for cardiovascular disease
Not available
Unique patients (not deduplicated)
$81
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
784 | $88 | $195 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
552 | $44 | $90 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
307 | $138 | $300 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
282 | $88 | $185 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
145 | $18 | $40 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
141 | $327 | $700 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
141 | $47 | $105 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
134 | $9 | $25 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
97 | $37 | $70 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
89 | $112 | $255 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
58 | $10 | $25 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
51 | $16 | $40 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
36 | $142 | $295 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
34 | $8 | $10 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
29 | $21 | $50 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
22 | $19 | $45 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
21 | $56 | $90 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
19 | $9 | $25 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
12 | $30 | $85 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
13.8% high complexity
39.0% medium
47.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,594
Total received (2018-2024)
Avg $656/year across 7 years
Top 42% in FL for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
184
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$498
2023
$777
2022
$917
2021
$410
2020
$454
2019
$1,257
2018
$281
Payments by company (2024)
Alexion Pharmaceuticals, Inc.
$78
AstraZeneca Pharmaceuticals LP
$76
Merck Sharp & Dohme LLC
$57
Novartis Pharmaceuticals Corporation
$47
Exact Sciences Corporation
$38
CALLIDITAS THERAPEUTICS US INC.
$35
Boston Scientific Corporation
$35
Takeda Pharmaceuticals U.S.A., Inc.
$29
Ethicon US, LLC
$19
Medtronic, Inc.
$18
Bayer Healthcare Pharmaceuticals Inc.
$17
Boehringer Ingelheim Pharmaceuticals, Inc.
$17
Esperion Therapeutics, Inc.
$16
Abbott Laboratories
$15
Top 3 companies account for 42.3% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic Vascular, Inc.
$1,015
AstraZeneca Pharmaceuticals LP
$490
Novartis Pharmaceuticals Corporation
$414
Merck Sharp & Dohme LLC
$326
Medtronic, Inc.
$297
Amarin Pharma Inc.
$229
Janssen Pharmaceuticals, Inc
$199
Esperion Therapeutics, Inc.
$140
Paratek Pharmaceuticals, Inc.
$114
Impulse Dynamics (USA) Inc.
$97
E.R. Squibb & Sons, L.L.C.
$89
Boehringer Ingelheim Pharmaceuticals, Inc.
$87
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$87
Allergan Inc.
$85
Alexion Pharmaceuticals, Inc.
$78
PFIZER INC.
$72
Merck Sharp & Dohme Corporation
$68
Genentech USA, Inc.
$55
Bardy Diagnostics, Inc.
$53
Edwards Lifesciences Corporation
$51
Boston Scientific Corporation
$49
Exact Sciences Corporation
$38
Bayer HealthCare Pharmaceuticals Inc.
$35
CALLIDITAS THERAPEUTICS US INC.
$35
BIOTRONIK INC.
$33
Takeda Pharmaceuticals U.S.A., Inc.
$29
Kowa Pharmaceuticals America, Inc.
$27
ARBOR PHARMACEUTICALS, INC.
$25
Calliditas Therapeutics US Inc.
$23
Gilead Sciences, Inc.
$22
Alnylam Pharmaceuticals Inc.
$20
Baxter Healthcare
$20
Ethicon US, LLC
$19
Amgen Inc.
$18
Novo Nordisk Inc
$18
Bayer Healthcare Pharmaceuticals Inc.
$17
Pacira Pharmaceuticals Incorporated
$16
Ultragenyx Pharmaceutical Inc.
$16
GE HealthCare
$15
Novavax Inc
$15
Abbott Laboratories
$15
Biosense Webster, Inc.
$14
Aurinia Pharma U.S., Inc.
$14
Eisai Inc.
$14
Top 3 companies account for 41.8% of all-time payments
Associated products mentioned in payments ›
ADJUVANTED · AVYCAZ · Adempas · Amplia MRI · BELSOMRA · BREZTRI · BRILINTA · CAMZYOS · CareLink · Carnation Ambulatory Monitor · Carto 3 System · Cologuard Collection Kit · Cryvista · DIFICID · Dayvigo · ELIQUIS · ENTRESTO · Edarbi · Edarbyclor · Edwards SAPIEN 3 Transcatheter Heart Valve · Exparel · FARXIGA · FREESTYLE LIBRE 3 · GIVLAARI · HYQVIA · Hillrom - Carnation Ambulatory Monitor · JARDIANCE · Kerendia · LEQVIO · LINQ II · LOKELMA · LUPKYNIS · LifeVest · Livalo · MYCARELINK · Micra · MyCareLink · NEXLETOL · NEXLIZET · NOVAVAX COVID-19 VACCINE · NUZYRA · OPTIMIZER · Ozempic · Repatha · Reveal LINQ · SAPIEN 3 Ultra RESILIA · STRATAFIX · TARPEYO · ULTOMIRIS · VENASEAL · VERQUVO · VYNDAQEL · Vascepa · WATCHMAN FLX · XARELTO · Xofluza
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Cardiologists in nearby ZIP areas
75
County median income
$58,535
Nearest hospital to ZIP centroid (approximate)
VILLAGES REGIONAL HOSPITAL, THE
10.2 mi
10.2 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Chesner is a cardiac imaging specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Chesner experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Chesner performed 784 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Chesner receive payments from pharmaceutical companies?
Yes. Dr. Chesner received a total of $4,594 from 44 companies across 184 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chesner's costs compare to other cardiologists in Summerfield?
Dr. Chesner's average Medicare payment per service is $81. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chesner) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Summerfield
Browse cardiologists in Summerfield ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in FL
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in FL
Which FL cardiologists receive the most from drug and device companies.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology